Dr. Patricia Defechereux lead’s the HOPE Community activities as the HOPE Community Engagement Coordinator.
Archives: People
Person
Feschotte
Our group will learn how T cells naturally silence endogenous retroviruses, which are ancient and permanent residents of our genome, to design new HIV repressors.
Gianella
Dr. Gianella is the executive director of the Last Gift Study, and she oversees all procedures related to recruitment, outreach, participant enrollment, and follow up. She is involved in the development of the rapid research autopsy procedures and the creation of lab-based techniques to process blood and tissues in an effort to characterize HIV reservoirs.
Hauber
Dr. Hauber works on developing a scalable cure for HIV using next generation genome editing methods.
Heinrich Pette Institute – Leibniz Institute for Experimental Virology
Parsons
Dr. Parsons will supervise and coordinate the execution of NHP studies.
Kallas
Dr. Kallas directs the clinical and community engagement efforts for the HOPE Collaboratory in Sao Paulo, Brazil.
University of Sao Paulo School of Medicine
Kibuuka
Dr. Kibuuka brings tremendous clinical trials experience plus HIV cohort study leadership and as a co-investigator, she participates in all procedures related to recruitment, outreach, participant enrollment, and follow up.
Kumar
As part of HOPE, Dr. Kumar will direct a research program for targeting nucleic-acid editing/modifying molecules to HIV-infected cells for suppressing viral reactivation and excising provirus and direct studies in humanized mouse models of HIV infection and latency
Lange
Dr. Lange contributes her expertise on chronic HIV infection to provide cellular models of clinical relevance to test newly developed therapeutic strategies developed in HOPE.
Leibniz Institute of Virology and University Medical Center Hamburg-Eppendorf
Murthy
Dr. Murthy’s lab will be developing innovative ways for delivering genome editing enzymes to T cells.
The University of California at Berkeley and the Innovative Genomics Institute